Hutch News
Results per Page:
Using a mouse model to combat the effects of lipodystrophy
From the Kensler Lab, Public Health Sciences Division
CAF-like cells remodel the Ewing sarcoma tumor microenvironment
From the Lawlor lab, Seattle Children’s Hospital and the Cancer Basic Biology Program of the Cancer Consortium
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
For a young woman who wanted children, proton therapy was the solution
Proton therapy spared Jane's healthy reproductive tissue during treatment for sarcoma.
Global collaborators at the Heart of the Hutch
Advancing science to address the burden of cancer in low- and middle-income countries
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
Interferon gamma brings the heat to cold tumors
From the Pollack Lab, Clinical Research Division
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Good News: Dr. Gary Gilliland speaks to members of Congress about federal research funding
Celebrating faculty and staff achievements
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Q&A with the author of ‘The Radium Girls’: A new story chronicles century-old fight for workplace safety
Author Kate Moore in conversation with cancer researcher Dr. Anne McTiernan
Good News: First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy
Celebrating faculty and staff achievements
First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy
Some types of sarcomas elicit a greater immune response than others, which sheds light on how immunotherapy could be used for this connective-tissue cancer, according to a new study in Cancer.
Deploying an ancient defense to kill cancer
In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug